Table of Content - Clostridium Difficile Diagnostics Market

Clostridium difficile infection (CDI) is diagnosed with the help of conventional laboratory testing methods, however, rapid point-of-care diagnostic tests are also available, which can save time and costs significantly. Clostridium difficile is a disease caused by bacteria. The illness manifests as a variety of symptoms, such as diarrhea, nausea, and colon inflammation. Furthermore, since antibiotics kill healthy bacteria in the body and promote the growth of C. difficile bacteria, they are also responsible for clostridium difficile infection when taken frequently. Watery diarrhoea, dehydration, fever, nausea, loss of appetite, and weight loss are typical signs of clostridium difficile infection. Diagnostic assays used for detection of CDI include enzyme immunoassays (EIAs) for toxins A/B. However, these are no longer considered stand-alone primary tests due to poor sensitivity. Other tests include glutamate dehydrogenase enzyme immunoassay and molecular assay based on polymerase chain reaction. Isothermal amplification technology has also been approved by the U.S. Food & Drug Administration for diagnosis of CDI. Manufacturers such as Cepheid, BD Diagnostics, DiaSorin, Inc., Abbott Laboratories, Thermo Fisher Diagnostics, and Luminex Corporation offer advanced diagnostic tests for clostridium difficile infection. For instance, Cepheid GeneXpert test, Nanosphere Verigene SP by Luminex Corporation offer sensitivity and timely results for clostridium difficile infection.

Market Dynamics

Factors such as rising prevalence of clostridium difficile infection, availability of precise and advanced diagnostic techniques such as real time-polymerase chain reaction (RT-PCR), and presence of generic versions of standard antibiotics such as metronidazole is expected to boost growth of the clostridium difficile diagnostics and treatment market over the forecast period. Furthermore, various organizations and manufacturers are working towards increasing awareness about clostridium difficile infection and its severity. For instance, in March 2018, C Diff Foundation awarded its “Making a Difference” award to CutisPharma, Inc.—a pharmaceutical company, for contribution of the company towards increasing awareness and expanding treatment options.

Key features of the study:

This report provides an in-depth analysis of the global clostridium difficile diagnostics market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global clostridium difficile diagnostics market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific, Merck & Co., Inc., Pfizer, Inc., Actelion Pharmaceuticals, Inc., Abbott Laboratories, Trinity Biotech Plc., Summit Therapeutics, Sanofi S.A., Novartis AG, and AstraZeneca Plc
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Clostridium Difficile Diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts1
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Clostridium Difficile Diagnostics market

Detailed Segmentation:

Global Clostridium Difficile Diagnostics Market, By Diagnostic Test:
- Enzyme Immunoassays
- Real-Time Polymerase Chain Reaction (RT-PCR)
- Nucleic Amplification Tests (NAAT)
- Stool Test
  - GDH Antigen Test
  - Toxin A and B Test
- Blood Test
- Colonoscopy or Sigmoidoscopy
- Others
Global Clostridium Difficile Diagnostics Market, By End User:
- Hospitals
- Diagnostic Centers
- Specialty Clinics
- Others
Global Clostridium Difficile Diagnostics Market, By Region:
- North America
  - By Country
    - U.S.
    - Canada
- Latin America
  - By Country
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - By Country
    - Germany
    - U.K.
    - France
    - Italy
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - By Country
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - By Country
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - By Region/Country
    - South Africa
    - Central Africa
    - North Africa
Company Profiles
- F. Hoffmann-La Roche Ltd *
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Thermo Fisher Scientific
- Merck & Co., Inc.
- Pfizer, Inc.
- Actelion Pharmaceuticals, Inc.
- Abbott Laboratories
- Trinity Biotech
- Summit Therapeutics
- Sanofi S.A.
- Novartis AG
- AstraZeneca Plc

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Diagnostic Test
  - Market Snapshot, By End User
  - Market Snapshot, By Region
  - Market Opportunity Map
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Drivers
  - Restraints
  - Market Opportunities
- Impact Analysis
- Key Highlights
- Recent Product Approvals/Launch
- Epidemiology
- Market Trends
- Porter’s Analysis
- PEST Analysis
- Technology Advancement
- Regulatory Scenario
Global Clostridium Difficile Diagnostics Market– COVID-19 Impact Analysis
- Overall Impact
- Impact on Supply and Demand
- COVID-19 Impact on the Clostridium Difficile Diagnostics Market
Global Clostridium Difficile Diagnostics Market, By Diagnostic Test, 2017 – 2030, (US$ Million)
- Overview
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2017 – 2030
  - Segment Trends
- Enzyme Immunoassays
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Real-Time Polymerase Chain Reaction (RT-PCR)
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Nucleic Amplification Tests (NAAT)
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Stool Test
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
  - GDH Antigen Test
  - Toxin A and B Test
- Blood Test
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Colonoscopy or Sigmoidoscopy
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Global Clostridium Difficile Diagnostics Market, By End User, 2017 – 2030, (US$ Million)
- Overview
  - Market Share Analysis, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, 2017 – 2030
  - Segment Trends
- Hospitals
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Diagnostic Centers
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Specialty Clinics
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Others
  - Overview
  - Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
Global Clostridium Difficile Diagnostics Market, By Region, 2017 – 2030, (US$ Million)
- Introduction
  - Market Share Analysis, By Region, 2022 and 2030 (%)
  - Y-o-Y Growth Analysis, For Regions, 2017–2030
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
    - Brazil
    - Mexico
    - Argentina
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
    - UK
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 – 2030, (US$ Million)
    - GCC
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Diagnostic Test, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  - Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 – 2030, (US$ Million)
    - North Africa
    - Central Africa
    - South Africa
Competitive Landscape
- F. Hoffmann-La Roche Ltd
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Thermo Fisher Scientific
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Merck & Co., Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Pfizer, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Actelion Pharmaceuticals, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Abbott Laboratories
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Trinity Biotech Plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Summit Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Sanofi S.A.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- AstraZeneca Plc
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
Section
- Research Methodology
- About Us

*Browse 25 market data tables and 29 figures on “Global Clostridium Difficile Diagnostics Market” - forecast to 2030

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now

Credibility and Certifications

860519526

9001:2015

27001:2022

Need a Custom Report?

EXISTING CLIENTELE